{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:00:10Z","timestamp":1791410410817,"version":"4.3.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T00:00:00Z","timestamp":1357344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12016-012-8346-7","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T20:54:01Z","timestamp":1357246441000},"page":"170-179","source":"Crossref","is-referenced-by-count":290,"title":["Genetics of Rheumatoid Arthritis \u2014 A Comprehensive Review"],"prefix":"10.1007","volume":"45","author":[{"given":"J\u00falia","family":"Kurk\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Besenyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Laki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor T.","family":"Glant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Mikecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,5]]},"reference":[{"issue":"3","key":"8346_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4(3):130\u2013136","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8346_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/BOR.0b013e32801127c8","volume":"19","author":"L Klareskog","year":"2007","unstructured":"Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19(1):49\u201354","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"8346_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","volume":"17","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Wesoly JZ, Huizinga TW (2005) Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol 17(3):299\u2013304","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"8346_CR4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ng1010-814","volume":"42","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Alemayehu WG, Verduijn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW et al (2010) Gene\u2013environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet 42(10):814\u2013816, author reply 816","journal-title":"Nat Genet"},{"issue":"3","key":"8346_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","volume":"9","author":"P Szodoray","year":"2010","unstructured":"Szodoray P, Szabo Z, Kapitany A, Gyetvai A, Lakos G, Szanto S et al (2010) Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9(3):140\u2013143","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8346_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/BOR.0b013e3283457524","volume":"23","author":"R Vries de","year":"2011","unstructured":"de Vries R (2011) Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 23(3):227\u2013232","journal-title":"Curr Opin Rheumatol"},{"key":"8346_CR7","doi-asserted-by":"crossref","unstructured":"Cooles FA, Isaacs JD. Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol;23(3):233\u201340","DOI":"10.1097\/BOR.0b013e32834518a3"},{"issue":"1","key":"8346_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","volume":"34","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, Vegvari A et al (2008) Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Clin Rev Allergy Immunol 34(1):26\u201331","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"8346_CR9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","volume":"2","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Padyukov L, Lorentzen J, Alfredsson L (2006) Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2(8):425\u2013433","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"10","key":"8346_CR10","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","volume":"50","author":"L Padyukov","year":"2004","unstructured":"Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004) A gene\u2013environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50(10):3085\u20133092","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8346_CR11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C et al (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69(6):964\u2013975","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8346_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","volume":"43","author":"AJ MacGregor","year":"2000","unstructured":"MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30\u201337","journal-title":"Arthritis Rheum"},{"key":"8346_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-3-15","volume":"3","author":"B Mesko","year":"2010","unstructured":"Mesko B, Poliska S, Szegedi A, Szekanecz Z, Palatka K, Papp M et al (2010) Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med Genomics 3:15","journal-title":"BMC Med Genomics"},{"issue":"6","key":"8346_CR14","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/art.22703","volume":"56","author":"HS Lee","year":"2007","unstructured":"Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H et al (2007) Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum 56(6):1745\u20131753","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8346_CR15","first-page":"32","volume":"10","author":"A Kapitany","year":"2008","unstructured":"Kapitany A, Szabo Z, Lakos G, Aleksza M, Vegvari A, Soos L et al (2008) Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Isr Med Assoc J 10(1):32\u201336","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"8346_CR16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jbspin.2011.05.018","volume":"78","author":"T Besenyei","year":"2011","unstructured":"Besenyei T, Gyetvai A, Szabo Z, Fekete A, Kapitany A, Szodoray P et al (2011) Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort. Joint Bone Spine 78(6):652\u2013653","journal-title":"Joint Bone Spine"},{"issue":"4","key":"8346_CR17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.berh.2011.10.010","volume":"25","author":"IC Scott","year":"2011","unstructured":"Scott IC, Steer S, Lewis CM, Cope AP (2011) Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis. Best Pract Res Clin Rheumatol 25(4):447\u2013468","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"8346_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.berh.2008.09.011","volume":"22","author":"O Vittecoq","year":"2008","unstructured":"Vittecoq O, Lequerre T, Goeb V, Le Loet X, Abdesselam TA, Klemmer N (2008) Smoking and inflammatory diseases. Best Pract Res Clin Rheumatol 22(5):923\u2013935","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"8346_CR19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","volume":"7","author":"L Davila","year":"2011","unstructured":"Davila L, Ranganathan P (2011) Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol 7(9):537\u2013550","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8346_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncprheum0072","volume":"2","author":"BN Cronstein","year":"2006","unstructured":"Cronstein BN (2006) Pharmacogenetics in the rheumatic diseases, from pret-a-porter to haute couture. Nat Clin Pract Rheumatol 2(1):2\u20133","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"8","key":"8346_CR21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2217\/14622416.9.8.1011","volume":"9","author":"MI Danila","year":"2008","unstructured":"Danila MI, Hughes LB, Bridges SL (2008) Pharmacogenetics of etanercept in rheumatoid arthritis. Pharmacogenomics 9(8):1011\u20131015","journal-title":"Pharmacogenomics"},{"issue":"5","key":"8346_CR22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.110961","volume":"39","author":"B Mesko","year":"2012","unstructured":"Mesko B, Poliska S, Szamosi S, Szekanecz Z, Podani J, Varadi C et al (2012) Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis. J Rheumatol 39(5):916\u2013928","journal-title":"J Rheumatol"},{"issue":"3","key":"8346_CR23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.30130","volume":"63","author":"D Plant","year":"2011","unstructured":"Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG et al (2011) Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 63(3):645\u2013653","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8346_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/1744666X.3.5.797","volume":"3","author":"M Centola","year":"2007","unstructured":"Centola M, Szekanecz Z, Kiss E, Zeher M, Szegedi G, Nakken B et al (2007) Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis. Expert Rev Clin Immunol 3(5):797\u2013806","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"8346_CR25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00439-010-0849-9","volume":"128","author":"T Feng","year":"2010","unstructured":"Feng T, Zhu X (2010) Genome-wide searching of rare genetic variants in WTCCC data. Hum Genet 128(3):269\u2013280","journal-title":"Hum Genet"},{"issue":"7289","key":"8346_CR26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nature08979","volume":"464","author":"N Craddock","year":"2010","unstructured":"Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S et al (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464(7289):713\u2013720","journal-title":"Nature"},{"issue":"2","key":"8346_CR27","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar1472","volume":"7","author":"VA Adarichev","year":"2005","unstructured":"Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT (2005) Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther 7(2):R196\u2013R207","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8346_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar2600","volume":"11","author":"E Ahlqvist","year":"2009","unstructured":"Ahlqvist E, Hultqvist M, Holmdahl R (2009) The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther 11(3):226","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8346_CR29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevImmunol.v23.i3.20","volume":"23","author":"TT Glant","year":"2003","unstructured":"Glant TT, Finnegan A, Mikecz K (2003) Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 23(3):199\u2013250","journal-title":"Crit Rev Immunol"},{"issue":"2","key":"8346_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.1780300211","volume":"30","author":"TT Glant","year":"1987","unstructured":"Glant TT, Mikecz K, Arzoumanian A, Poole AR (1987) Proteoglycan-induced arthritis in BALB\/c mice. Clinical features and histopathology. Arthritis Rheum 30(2):201\u2013212","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8346_CR31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00000441-200404000-00004","volume":"327","author":"TT Glant","year":"2004","unstructured":"Glant TT, Adarichev VA, Nesterovitch AB, Szanto S, Oswald JP, Jacobs JJ et al (2004) Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis. Am J Med Sci 327(4):188\u2013195","journal-title":"Am J Med Sci"},{"issue":"3","key":"8346_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","volume":"36","author":"CM Deighton","year":"1989","unstructured":"Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36(3):178\u2013182","journal-title":"Clin Genet"},{"issue":"11","key":"8346_CR33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30(11):1205\u20131213","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8346_CR34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.24385","volume":"60","author":"D Woude van der","year":"2009","unstructured":"van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J et al (2009) Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 60(4):916\u2013923","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8346_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.22373","volume":"56","author":"AH Helm-van Mil van der","year":"2007","unstructured":"van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE (2007) The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 56(2):425\u2013432","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8346_CR36","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.20989","volume":"52","author":"ST Montcel du","year":"2005","unstructured":"du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S et al (2005) New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 52(4):1063\u20131068","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8346_CR37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/art.27366","volume":"62","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Lie BA, Lundstrom E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ et al (2010) Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 62(5):1236\u20131245","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8346_CR38","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.34421","volume":"64","author":"J Laki","year":"2012","unstructured":"Laki J, Lundstrom E, Snir O, Ronnelid J, Ganji I, Catrina AI et al (2012) Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis. Arthritis Rheum 64(7):2078\u20132084","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8346_CR39","first-page":"2299","volume":"32","author":"S Zsilak","year":"2005","unstructured":"Zsilak S, Gal J, Hodinka L, Rajczy K, Balog A, Sipka S et al (2005) HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family. J Rheumatol 32(12):2299\u20132302","journal-title":"J Rheumatol"},{"issue":"5","key":"8346_CR40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/art.1780370511","volume":"37","author":"D Jawaheer","year":"1994","unstructured":"Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA et al (1994) \"Homozygosity\" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37(5):681\u2013686","journal-title":"Arthritis Rheum"},{"key":"8346_CR41","doi-asserted-by":"crossref","unstructured":"Gyetvai A, Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, et al. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies. Rheumatology (Oxford) 2009","DOI":"10.1093\/rheumatology\/kep338"},{"issue":"11","key":"8346_CR42","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","volume":"52","author":"TW Huizinga","year":"2005","unstructured":"Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D et al (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52(11):3433\u20133438","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8346_CR43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00251-011-0528-6","volume":"63","author":"M Bax","year":"2011","unstructured":"Bax M, van Heemst J, Huizinga TW, Toes RE (2011) Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 63(8):459\u2013466","journal-title":"Immunogenetics"},{"issue":"2","key":"8346_CR44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/ard.2007.072819","volume":"67","author":"B Farago","year":"2008","unstructured":"Farago B, Magyari L, Safrany E, Csongei V, Jaromi L, Horvatovich K et al (2008) Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 67(2):248\u2013250","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8346_CR45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00296-008-0771-9","volume":"29","author":"B Farago","year":"2009","unstructured":"Farago B, Talian GC, Komlosi K, Nagy G, Berki T, Gyetvai A et al (2009) Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 29(7):793\u2013796","journal-title":"Rheumatol Int"},{"issue":"6","key":"8346_CR46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","volume":"42","author":"EA Stahl","year":"2010","unstructured":"Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42(6):508\u2013514","journal-title":"Nat Genet"},{"issue":"8","key":"8346_CR47","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/ken192","volume":"47","author":"V Goeb","year":"2008","unstructured":"Goeb V, Dieude P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F et al (2008) Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology (Oxford) 47(8):1208\u20131212","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8346_CR48","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.22570","volume":"56","author":"S Cha","year":"2007","unstructured":"Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC (2007) Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum 56(5):1454\u20131463","journal-title":"Arthritis Rheum"},{"key":"8346_CR49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1423.004","volume":"1110","author":"G Poor","year":"2007","unstructured":"Poor G, Nagy ZB, Schmidt Z, Brozik M, Meretey K, Gergely P Jr (2007) Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Ann N Y Acad Sci 1110:23\u201332","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"8346_CR50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","volume":"34","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34(4):395\u2013402","journal-title":"Nat Genet"},{"issue":"8","key":"8346_CR51","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","volume":"60","author":"MP Linden van der","year":"2009","unstructured":"van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S et al (2009) Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 60(8):2242\u20132247","journal-title":"Arthritis Rheum"},{"key":"8346_CR52","doi-asserted-by":"crossref","unstructured":"Liang YL, Wu H, Shen X, Li PQ, Yang XQ, Liang L, et al. Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis. Mol Biol Rep 2012.","DOI":"10.1007\/s11033-012-1754-1"},{"issue":"12","key":"8346_CR53","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","volume":"357","author":"RM Plenge","year":"2007","unstructured":"Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B et al (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis\u2014a genomewide study. N Engl J Med 357(12):1199\u20131209","journal-title":"N Engl J Med"},{"issue":"11","key":"8346_CR54","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3899\/jrheum.080186","volume":"35","author":"YH Lee","year":"2008","unstructured":"Lee YH, Ji JD, Song GG (2008) Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis. J Rheumatol 35(11):2129\u20132135","journal-title":"J Rheumatol"},{"issue":"6","key":"8346_CR55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng.583","volume":"42","author":"Y Kochi","year":"2010","unstructured":"Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A et al (2010) A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 42(6):515\u2013519","journal-title":"Nat Genet"},{"issue":"9","key":"8346_CR56","first-page":"356","volume":"69","author":"Z Szekanecz","year":"2011","unstructured":"Szekanecz Z, Koch AE, Tak PP (2011) Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. Neth J Med 69(9):356\u2013366","journal-title":"Neth J Med"},{"issue":"1","key":"8346_CR57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.24135","volume":"60","author":"B Ding","year":"2009","unstructured":"Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR et al (2009) Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 60(1):30\u201338","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8346_CR58","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","volume":"56","author":"KN Verpoort","year":"2007","unstructured":"Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF et al (2007) Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 56(12):3949\u20133952","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8346_CR59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrrheum.2011.28","volume":"7","author":"NA Daha","year":"2011","unstructured":"Daha NA, Toes RE (2011) Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease? Nat Rev Rheumatol 7(4):202\u2013203","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"8346_CR60","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","volume":"8","author":"M Pedersen","year":"2006","unstructured":"Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J et al (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 8(4):R133","journal-title":"Arthritis Res Ther"},{"key":"8346_CR61","doi-asserted-by":"crossref","unstructured":"Perricone C, Ceccarelli F, Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev, 10(10):599\u2013608","DOI":"10.1016\/j.autrev.2011.04.021"},{"issue":"6","key":"8346_CR62","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2011-200337","volume":"71","author":"A Ruyssen-Witrand","year":"2012","unstructured":"Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loet X, Sibilia J et al (2012) Fcgamma receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 71(6):875\u2013877","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8346_CR63","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/1529-0131(200111)44:11<2525::AID-ART432>3.0.CO;2-B","volume":"44","author":"AE Ede van","year":"2001","unstructured":"van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA et al (2001) The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 44(11):2525\u20132530","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8346_CR64","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/ard.2003.016337","volume":"63","author":"Y Berkun","year":"2004","unstructured":"Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T et al (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63(10):1227\u20131231","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8346_CR65","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00008571-200411000-00004","volume":"14","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Kremer J, Lein DO, Capps R, Barham R, Meyer G et al (2004) Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis. Pharmacogenetics 14(11):733\u2013739","journal-title":"Pharmacogenetics"},{"issue":"9","key":"8346_CR66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5414\/CPP42496","volume":"42","author":"A Pawlik","year":"2004","unstructured":"Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I, Gawronska-Szklarz B (2004) The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther 42(9):496\u2013503","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"8346_CR67","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/14622416.7.5.683","volume":"7","author":"B Tolusso","year":"2006","unstructured":"Tolusso B, Pietrapertosa D, Morelli A, De Santis M, Gremese E, Farina G et al (2006) IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7(5):683\u2013695","journal-title":"Pharmacogenomics"},{"issue":"7","key":"8346_CR68","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.2007.069872","volume":"66","author":"RF Vollenhoven van","year":"2007","unstructured":"van Vollenhoven RF (2007) Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue. Ann Rheum Dis 66(7):849\u2013851","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8346-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T18:39:30Z","timestamp":1562524770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,5]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["8346"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8346-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,5]]}}}